Artificial Inteligence Biotech Technical Review 
Crunchbase News
NOVEMBER 1, 2024
There may not have been a $1 billion raise this week, but large money deals did abound. startups raised half a billion dollars apiece, and another eight raised $100 million or more, with industries from cybersecurity to biotech to AI represented. In 2020, Insight Partners bought a large stake in the startup. billion valuation.
N2Growth Blog
OCTOBER 23, 2023
With the constant advancements in technology and research, businesses in this sector require leaders who possess a deep understanding of the scientific landscape and the business acumen to drive growth and innovation. The life sciences industry is known for its unique challenges in recruiting and hiring.
Crunchbase News
OCTOBER 4, 2024
The past quarter was a quirky one for North America startup funding, with a slowdown in some pockets counterbalanced by continued high enthusiasm around artificial intelligence, Crunchbase data shows. While the IPO market wasn’t especially active, we did see a handful of public offerings, predominantly in the biotech sector.
CIO
APRIL 17, 2024
Normally, a CCO develops ideas about what the market needs and communicates them to a design team, which produces sketches to then be reviewed by the CCO. But what we’re learning from public announcements like these might just scratch the surface of gen AI use cases for the enterprise.
TechCrunch
MARCH 17, 2023
Best practices for leveraging artificial intelligence and machine learning in 2023 Zero-based budgeting: A proven framework for extending runway Image Credits: Getty Images It’s critical to make every dollar count in this environment, but pulling back too much in the wrong places can reduce momentum across your entire organization. “The
Crunchbase News
JUNE 14, 2024
AI, biotech, space tech and cybersecurity also saw good-sized raises. Then, late last year, Cruise suspended its self-driving taxi program across the country after losing its permit to operate in San Francisco due to an incident with a pedestrian. Alzheon , $100M, biotech: Alzheon was the next biotech to raise big this week.
Crunchbase News
NOVEMBER 22, 2024
To a great degree, the largest rounds of the year went to a handful of AI companies working on large language models and underlying technologies to scale them. While the Boston startup scene is famous for biotech and deeptech talent, the city has lagged other hubs in creation of ultra-high-valuation AI unicorns.
Expert insights. Personalized for you.
107 
Let's personalize your content